Table 1 of Stålhammar, Mol Vis 2019; 25:502-516.
n = | 32 |
---|---|
Mean age at enucleation, years (min—max) | 62 (24–92) |
Sex, n (%) | |
Female | 15 (47) |
Male | 17 (53) |
Tumor location, n (%) | |
Choroid only | 22 (69) |
Choroid and ciliary body | 7 (22) |
Choroid, ciliary body and iris | 1 (3) |
Iris only, or ciliary body and iris | 2 (6) |
Cell type, n (%) | |
Spindle | 2 (6) |
Epitheloid | 4 (13) |
Mixed | 26 (81) |
Mean tumor thickness, mm (min—max) | 8.8 (1.1–17.4) |
Mean tumor diameter, mm (min—max) | 15.5 (4.8–22.5) |
Previous brachytherapy, n (%) | |
No | 32 (100) |
Yes | 0 (0) |
AJCC T-category, n (%) | |
1 | 2 (6) |
2 | 6 (19) |
3 | 16 (50) |
4 | 8 (25) |
Gene expression class, n (%) | |
1a | 7 (23) |
1b | 8 (25) |
2 | 15 (47) |
Na | 2 (6) |
Manual BAP1 classification, n (%) | |
High | 12 (38) |
Low | 20 (63) |
Follow-up months, mean (SD, min—max) | 28 (20, 2–56) |
Metastasis, n (%) | |
No | 18 (56%) |
Yes | 14 (44%) |